{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:48Z","timestamp":1790892648547,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["\/2023\/142"],"award-info":[{"award-number":["\/2023\/142"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["IICT\/IAEC\/54\/2018"],"award-info":[{"award-number":["IICT\/IAEC\/54\/2018"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002826","name":"IICT CSIR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.111070","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:09:59Z","timestamp":1697641799000},"page":"111070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"PB","title":["Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis"],"prefix":"10.1016","volume":"124","author":[{"given":"Gajalakshmi","family":"Singuru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriravali","family":"Pulipaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-2548","authenticated-orcid":false,"given":"Altab","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Balaji Andugulapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamannar","family":"Thennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-7553","authenticated-orcid":false,"given":"Srigiridhar","family":"Kotamraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2023.111070_b0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000471488","article-title":"The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function","volume":"10","author":"Goossens","year":"2017","journal-title":"Obes. Facts"},{"issue":"4","key":"10.1016\/j.intimp.2023.111070_b0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol. [Internet]"},{"issue":"7","key":"10.1016\/j.intimp.2023.111070_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol. [Internet]"},{"issue":"2","key":"10.1016\/j.intimp.2023.111070_b0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.intimp.2023.111070_b0025","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1172\/JCI129192","article-title":"Deciphering the cellular interplays underlying obesityinduced adipose tissue fibrosis","volume":"129","author":"Marcelin","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and its management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutr. Clin. Pract."},{"issue":"4","key":"10.1016\/j.intimp.2023.111070_b0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol. [Internet]"},{"issue":"10290","key":"10.1016\/j.intimp.2023.111070_b0040","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet [Internet]"},{"issue":"9","key":"10.1016\/j.intimp.2023.111070_b0045","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.intimp.2023.111070_b0050","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/21623945.2019.1609202","article-title":"Lymphocytes upregulate CD36 in adipose tissue and liver","volume":"8","author":"Couturier","year":"2019","journal-title":"Adipocyte [Internet]"},{"issue":"2","key":"10.1016\/j.intimp.2023.111070_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0211568","article-title":"Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver","volume":"14","author":"Muise","year":"2019","journal-title":"PLoS One"},{"issue":"February","key":"10.1016\/j.intimp.2023.111070_b0065","first-page":"1","article-title":"Oxidative stress in non-alcoholic fatty liver disease. An updated mini review","volume":"8","author":"Delli Bovi","year":"2021","journal-title":"Front Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.111070_b0070","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis. [Internet]"},{"issue":"March","key":"10.1016\/j.intimp.2023.111070_b0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med. [Internet]"},{"issue":"December","key":"10.1016\/j.intimp.2023.111070_b0080","first-page":"1","article-title":"Mitochondrial targeting therapeutics: promising role of natural products in non-alcoholic fatty liver disease","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.111070_b0085","article-title":"Nonalcoholic fatty liver disease (Nafld). mitochondria as players and targets of therapies?","volume":"22","author":"Di","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111070_b0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(99)00069-1","volume":"41","author":"Murphy","year":"2000","journal-title":"Adv. Drug Deliv."},{"issue":"36","key":"10.1016\/j.intimp.2023.111070_b0095","doi-asserted-by":"crossref","first-page":"37575","DOI":"10.1074\/jbc.M404003200","article-title":"Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis","volume":"279","author":"Dhanasekaran","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2023.111070_b0100","first-page":"1","article-title":"Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis","volume":"2016","author":"Karnewar","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2023.111070_b0105","first-page":"1351","article-title":"Inhibition of arachidonic acid 5-lipoxygenase of human polymorphonuclear leukocytes by esculetin","volume":"43","author":"Panossian","year":"1984","journal-title":"Biomed. Biochim. Acta"},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1008139412588","article-title":"Structure-activity relationship of antioxidants for inhibitors of linoleic acid hydroperoxide-induced toxicity in cultured human umbilical vein endothelial cells","volume":"35","author":"Kaneko","year":"2001","journal-title":"Cytotechnology"},{"issue":"7","key":"10.1016\/j.intimp.2023.111070_b0115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1248\/bpb.b17-00724","article-title":"AMPK-mediated regulation of lipid metabolism by phosphorylation","volume":"41","author":"Wang","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.celrep.2018.12.036","article-title":"Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD","volume":"26","author":"Garcia","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.intimp.2023.111070_b0125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1159\/000493650","article-title":"Fisetin protects against hepatic steatosis through regulation of the Sirt1\/AMPK and fatty acid \u03b2-oxidation signaling pathway in high-fat diet-induced obese mice","volume":"49","author":"Liou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"45","key":"10.1016\/j.intimp.2023.111070_b0130","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.3748\/wjg.v25.i45.6607","article-title":"LB100 ameliorates nonalcoholic fatty liver disease via the AMPK\/Sirt1 pathway","volume":"25","author":"Chen","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"92","key":"10.1016\/j.intimp.2023.111070_b0135","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1039\/D1CC03497A","article-title":"A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent","volume":"57","author":"Shaikh","year":"2021","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10616-004-3903-4","article-title":"Oil red-O stains non-adipogenic cells: a precautionary note","volume":"46","author":"Kinkel","year":"2004","journal-title":"Cytotechnology"},{"issue":"6","key":"10.1016\/j.intimp.2023.111070_b0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.intimp.2023.111070_b0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.intimp.2023.111070_b0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver-from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-017-0206-2","article-title":"Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults","volume":"14","author":"Dai","year":"2017","journal-title":"Nutr. Metab."},{"issue":"11","key":"10.1016\/j.intimp.2023.111070_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111600","article-title":"Fat mass and obesity associated (FTO) gene and hepatic glucose and lipid metabolism","volume":"10","author":"Mizuno","year":"2018","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.intimp.2023.111070_b0170","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1210\/en.2003-0849","article-title":"Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity","volume":"144","author":"Ruderman","year":"2003","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111070_b0175","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology [Internet]"},{"issue":"July","key":"10.1016\/j.intimp.2023.111070_b0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2022.07.012","article-title":"Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe \u2212 \/ \u2212 mice","volume":"356","author":"Karnewar","year":"2022","journal-title":"Atherosclerosis [Internet]"},{"issue":"7","key":"10.1016\/j.intimp.2023.111070_b0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol. [Internet]"},{"key":"10.1016\/j.intimp.2023.111070_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/943614","article-title":"Renal and vascular mechanisms of thiazolidinedione-induced fluid retention","volume":"2008","author":"Yang","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.intimp.2023.111070_b0195","unstructured":"G. Targher, C.B. Catheter, c or r e sp ondence Pioglitazone in Nonalcoholic Steatohepatitis (2007) 2006\u20132008."},{"issue":"12","key":"10.1016\/j.intimp.2023.111070_b0200","article-title":"Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"2013","author":"Eslami","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"26","key":"10.1016\/j.intimp.2023.111070_b0205","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1021\/acs.jafc.8b01831","article-title":"Improvement of lipid and glucose metabolism by capsiate in palmitic acid-treated HepG2 cells via activation of the AMPK\/SIRT1 signaling pathway","volume":"66","author":"Zang","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.intimp.2023.111070_b0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1194\/jlr.M041863","article-title":"CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis","volume":"55","author":"Clugston","year":"2014","journal-title":"J. Lipid Res."},{"issue":"57","key":"10.1016\/j.intimp.2023.111070_b0215","first-page":"101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"2022","author":"Zeng","year":"2021","journal-title":"Mol. Metab. [Internet]"},{"issue":"5","key":"10.1016\/j.intimp.2023.111070_b0220","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111070_b0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1113\/JP271457","article-title":"The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance","volume":"594","author":"Pal","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.intimp.2023.111070_b0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jff.2014.12.004","article-title":"Esculetin, a coumarin derivative, suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes","volume":"12","author":"Kim","year":"2015","journal-title":"J. Funct. Foods [Internet]."},{"issue":"4","key":"10.1016\/j.intimp.2023.111070_b0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab. [Internet]"},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0240","first-page":"1","article-title":"Liver regeneration and fibrosis after inflammation","volume":"36","author":"Tanaka","year":"2016","journal-title":"Inflamm. Regen. [Internet]"},{"issue":"7","key":"10.1016\/j.intimp.2023.111070_b0245","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111070_b0250","first-page":"40","article-title":"Drugs for non-alcoholic steatohepatitis (NASH): quest for the holy grail","volume":"9","author":"Sharma","year":"2021","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923013966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923013966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:08:53Z","timestamp":1761588533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923013966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"alternative-id":["S1567576923013966"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111070","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111070"}}